GILEAD EN GALAPAGOS PRESENTEREN NIEUWE DATA OVER FILGOTINIB OP HET JAARLIJKSE ACR/ARP 2019 CONGRES

NEXT STORY
Paratek Announces Top Line Results of Phase 2 Clinical Studies of Omadacycline in Urinary Tract Infections
PREV STORY
Cytokinetics Reports Third Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Beroni Group to Hold the Third Precision Medicine & Medical Care and Aging International Forum (with Conference Theme “Innovation Driving Development, Technology Leading Future”) in Tianjin, China on December 7-8, 2019

author_avatar
NASDAQ Market News

ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. ...

author_avatar
NASDAQ Market News

Inventiva completes a capital increase of €15 m subscribed by existing shareholders

author_avatar
NASDAQ Market News